Journal
NATURE REVIEWS NEUROLOGY
Volume 9, Issue 8, Pages 445-454Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneurol.2013.132
Keywords
-
Categories
Funding
- Leading Edge Endowment Fund
- Canada Excellence Research Chair
- Don Rix Chair in Genetic Medicine
Ask authors/readers for more resources
Parkinson disease (PD) is a multifactorial neurodegenerative disease that was long considered the result of environmental factors. In the past 15 years, however, a genetic aetiology for PD has begun to emerge. Here, we review results from linkage and next-generation sequencing studies of familial parkinsonism, as well as candidate gene and genome-wide association findings in sporadic PD. In these studies, many of the genetic findings overlap, despite different designs and study populations, highlighting novel therapeutic targets. The molecular results delineate a sequence of pathological events whereby deficits in synaptic exocytosis and endocytosis, endosomal trafficking, lysosome-mediated autophagy and mitochondrial maintenance increase susceptibility to PD. These discoveries provide the rationale, molecular insight and research tools to develop neuroprotective and disease-modifying therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available